ExSight Ventures
New York City, New Yorkexsightventures.com
Overview
ExSight Ventures is a returns-oriented, mission-focused life sciences venture capital firm that specializes in early-stage investments in innovative ophthalmic diagnostic and treatment solutions. The firm was established to address the lack of early-stage funding for life science companies and is led by a team that includes two accomplished retinal surgeons, leveraging their deep domain expertise. It invests in pre-seed to Series B rounds, focusing on therapeutics, devices, and diagnostics within the eye care sector.
Portfolio Companies
7
Website
exsightventures.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| RevOpsis Therapeutics | Sep 2025 | VC Round | Lead |
| InflammX Therapeutics | Jan 2025 | Series A | Co-investor |
| Horizon Surgical Systems | Oct 2024 | Series A | Lead |
| ONL Therapeutics | Sep 2024 | Series D | Co-investor |
| ONL Therapeutics | Aug 2023 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.